Abstract 4635: Efficacy and Safety of Baxdrostat for Hypertension: A Systematic Review and Meta-Analysis of Three Phase 2/3 Randomized Controlled Trials
Introduction: Baxdrostat is a selective aldosterone synthase (CYP11B2) inhibitor evaluated in three phase 2/3 randomized controlled trials (RCTs) for treatment-resistant and uncontrolled hypertension. However, no dedicated quantitative synthesis has characterized its blood pressure-lowering efficacy, dose-response r...